Cargando…

Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor

BACKGROUND: There are various alternative first-line therapeutic options besides tyrosine kinase inhibitors (TKIs) for metastatic renal cell carcinoma (mRCC). To inform therapeutic decision-making for such patients, this study aimed to identify predictive factors for resistance to TKI. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales:	Teishima, Jun, Murata, Daiki, Inoue, Shogo, Hayashi, Tetsutaro, Mita, Koji, Hasegawa, Yasuhisa, Kato, Masao, Kajiwara, Mitsuru, Shigeta, Masanobu, Maruyama, Satoshi, Moriyama, Hiroyuki, Fujiwara, Seiji, Matsubara, Akio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Editor Recommendations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8772668/ https://www.ncbi.nlm.nih.gov/pubmed/35069080 http://dx.doi.org/10.1097/CU9.0000000000000042

Ejemplares similares

Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy
por: Teishima, Jun, et al.
Publicado: (2021)

Significance of timing of therapeutic line on effectiveness of nivolumab for metastatic renal cell carcinoma
por: Teishima, Jun, et al.
Publicado: (2023)

Change of preoperative symptoms of the late-onset hypogonadism syndrome after robot-assisted radical prostatectomy
por: Teishima, Jun, et al.
Publicado: (2021)

Effect of penile rehabilitation with low intensity extracorporeal shock wave therapy on erectile function recovery following robot-assisted laparoscopic prostatectomy
por: Inoue, Shogo, et al.
Publicado: (2020)

AB171. Regeneration of rat corpus cavernosa tissue after transplantation of human bone-marrow-derived CD133(+) cells
por: Inoue, Shogo, et al.
Publicado: (2015)

Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy
por: TEISHIMA, JUN, et al.
Publicado: (2014)

Fibroblast Growth Factor Family in the Progression of Prostate Cancer
por: Teishima, Jun, et al.
Publicado: (2019)

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)
por: Pons-Estel, Bernardo A, et al.
Publicado: (2018)

Effect of non‐alcoholic beer containing matured hop bitter acids on mood states in healthy adults: A single‐arm pilot study
por: Fukuda, Takafumi, et al.
Publicado: (2021)

Heidelberg Consensus Recommendations on Trustmarks
Publicado: (2000)

Treatment recommendations for psoriatic arthritis
por: Ritchlin, C T, et al.
Publicado: (2009)

EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis
por: Gerlag, Danielle M, et al.
Publicado: (2012)

Treating rheumatoid arthritis to target: the patient version of the international recommendations
por: de Wit, M P T, et al.
Publicado: (2011)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
por: Braun, J, et al.
Publicado: (2011)

Treating rheumatoid arthritis to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2010)

Updated clinical recommendations for the use of tibolone in Asian women
por: Huang, K-E., et al.
Publicado: (2010)

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
por: Bertsias, George K, et al.
Publicado: (2012)

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
por: Visser, K, et al.
Publicado: (2008)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs
por: Smolen, Josef S, et al.
Publicado: (2010)

Multinational evidence-based recommendations on how to investigate and follow-up undifferentiated peripheral inflammatory arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative
por: Machado, P, et al.
Publicado: (2010)

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update
por: Smolen, Josef S, et al.
Publicado: (2014)

Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2014)

Multinational evidence-based recommendations for the diagnosis and management of gout: integrating systematic literature review and expert opinion of a broad panel of rheumatologists in the 3e initiative
por: Sivera, Francisca, et al.
Publicado: (2014)

Guidelines for the genetic diagnosis of hereditary recurrent fevers
por: Shinar, Y, et al.
Publicado: (2012)

Development of EULAR recommendations for the reporting of clinical trial extension studies in rheumatology
por: Buch, Maya H, et al.
Publicado: (2015)

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force
por: Smolen, Josef S, et al.
Publicado: (2016)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Consensus-based recommendations for the management of juvenile dermatomyositis
por: Enders, Felicitas Bellutti, et al.
Publicado: (2017)

Recommendations on hip fractures
por: Wendt, K., et al.
Publicado: (2016)

Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force
por: Smolen, Josef S, et al.
Publicado: (2018)

Application of genome analysis strategies in the clinical testing for pediatric diseases
por: Jin, Yaqiong, et al.
Publicado: (2018)

Consensus-based recommendations for the management of juvenile localised scleroderma
por: Zulian, Francesco, et al.
Publicado: (2019)

Guidelines for Diagnosis and Treatment of Chronic Lymphocytic Leukemia. Krohem B-Cll 2017
por: Jakšić, Branimir, et al.
Publicado: (2018)

Clinical relevance of HEp-2 indirect immunofluorescent patterns: the International Consensus on ANA patterns (ICAP) perspective
por: Damoiseaux, Jan, et al.
Publicado: (2019)

Occupational exposure limits for cumene, 2,4‐dichlorophenoxy acetic acid, silicon carbide whisker, benzyl alcohol, and methylamine, and carcinogenicity, occupational sensitizer, and reproductive toxicant classifications
Publicado: (2019)

Preparing Undergraduates for the Global Future of Health Care
por: Amerson, Roxanne
Publicado: (2019)

Physical activity and osteoarthritis: a consensus study to harmonise self-reporting methods of physical activity across international cohorts
por: Gates, L. S., et al.
Publicado: (2017)

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
por: Fisher, Benjamin A, et al.
Publicado: (2017)

RECOMMENDATIONS FOR PERIOPERATIVE MANAGEMENT OF PATIENTS WITH CARDIAC IMPLANTABLE ELECTRONIC DEVICES
por: Pavlović, Nikola, et al.
Publicado: (2018)

Perinatal-Neonatal Management of COVID-19 Infection — Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP)
por: Chawla, Deepak, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ia6c37ijvr0ffkd6psgumpma0v